Research Papers:

Association of CKIP-1 P21A polymorphism with risk of chronic heart failure in a Chinese population

Mu-Peng Li, Yan-Jiao Zhang, Xiao-Lei Hu, Ji-Peng Zhou, Yong-Long Yang, Li-Ming Peng, Hong Qi, Tian-Lun Yang and Xiao-Ping Chen _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:36545-36552. https://doi.org/10.18632/oncotarget.16614

Metrics: PDF 1582 views  |   HTML 1886 views  |   ?  


Mu-Peng Li1,2, Yan-Jiao Zhang1,2, Xiao-Lei Hu1,2, Ji-Peng Zhou1,2, Yong-Long Yang3, Li-Ming Peng4, Hong Qi4, Tian-Lun Yang4 and Xiao-Ping Chen1,2

1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, P. R. China

2Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, Hunan, P. R. China

3Haikou People’s Hospital and Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou 570311, Hainan, P. R. China

4Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha 410008, Hunan, P. R. China

Correspondence to:

Xiao-Ping Chen, email: [email protected]

Keywords: CKIP-1, polymorphism, cardiac hypertrophy, chronic heart failure, prognosis

Received: December 08, 2016    Accepted: February 28, 2017    Published: March 28, 2017


Pathological cardiac hypertrophy is an independent risk factor for chronic heart failure. Casein kinase-2 interacting protein-1 (CKIP-1) can inhibit pathological cardiac hypertrophy. Therefore, we investigated whether CKIP-1 nonsynonymous polymorphism rs2306235 (Pro21Ala) contributes to risk and prognosis of chronic heart failure in a Chinese population.A total of 923 adult patients with chronic heart failure and 1020 age- and gender-matched healthy controls were recruited. CKIP-1 rs2306235 polymorphism was genotyped using PCR-restriction fragment length polymorphism. Additional follow-up data for 140 chronic heart failure patients was evaluated. The rs2306235 G allele was associated with an increased risk of chronic heart failure (OR = 1.38, 95% CI = 1.09-1.75, p = 0.007), especially in patients with hypertension (OR = 1.45, 95% CI = 1.09-1.75, p = 0.006) and coronary heart disease (OR = 1.41, 95% CI = 1.09-1.83, p = 0.010) after adjustment for multiple cardiovascular risk factors. However, rs2306235 polymorphism was not associated with cardiovascular mortality in chronic heart failure (p = 0.875). CKIP-1 rs2306235 polymorphism may be a risk factor for chronic heart failure in a Chinese Han population.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 16614